The impact of taurolock versus heparin lock for the maintenance of central vein catheters patency in pediatric tertiary care hospitals
محل انتشار: مجله کشت ها و گردش خون، دوره: 1، شماره: 4
سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 266
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_QJVC-1-4_002
تاریخ نمایه سازی: 24 آبان 1401
چکیده مقاله:
Background and Aim:Central vein access is a common procedure in infants and neonates. In this regard, cutdown is a common central venous access technique. However, it is associated with complications, including catheter occlusion, infection, and spontaneous withdrawal. Catheter occlusion is a common complication of the cutdown procedure and causes catheter dysfunction and subsequent catheter removal. In this study, we compared the effect of heparin lock with Taurolock on the maintenance of central vein catheter potency placed in the greater saphenous vein at the saphenofemoral junction and their subsequent complications.
Materials and Methods:The children admitted to the pediatric hospital who required central vein access between December ۲۰۱۵ and July ۲۰۱۹ were recruited. There were two groups of patients. The first group received ۰.۵ mL Taurolock solution. The solution contains (cyclo)-taurolidine, heparin ۵۰۰ IU/mL, and citrate (۴%) before the catheter gets locked (Taurolock group). Another group received ۰.۵ mL heparin (contains ۵۰۰ IU/mL heparin) before the catheter lock (heparin lock group). After the treatment period, the average duration of catheter usage and heparin-induced bleeding complications were evaluated.
Results: The average duration of catheter function was ۱۳.۴ days and ۹.۳ days in the Taurolock group, and the heparin lock group, respectively. The coagulation tests were performed on ۱۷۹ patients (۳۳.۹%) during hospitalization, no heparin-induced coagulopathies were reported.
Conclusion: Using Taurolock after catheter use could significantly reduce catheter occlusion and increase the duration of catheter function. Taurolock reduces costs, prevents delays in treatment, and decreases pain sensation and discomfort in patients.
کلیدواژه ها:
نویسندگان
Mahdi Bassirian
Student Research Committee, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.
Amrollah Salimi
Department of Surgery, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
Enayatollah Noori
Department of Surgery, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
Zahra Moeini
Department of Surgery, School of Medicine, Qom University of Medical Sciences, Qom, Iran.
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :